Education
About Us
Working with TipRanks
Follow Us
Cyfuse Biomedical K.K. (JP:4892)
:4892
4892 Stock Chart & Stats
Day’s Range― - ―
52-Week Range¥430.00 - ¥1,412.00
Previous CloseN/A
Volume38.50K
Average Volume (3M)92.85K
Market Cap
¥6.80B
Enterprise Value¥5.87B
Total Cash (Recent Filing)¥3.05B
Total Debt (Recent Filing)¥852.00M
Price to Earnings (P/E)―
Beta0.69
Next Earnings
Aug 19, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-19.90
Shares Outstanding8,373,600
10 Day Avg. Volume145,460
30 Day Avg. Volume92,850
Financial Highlights & Ratios
PEG Ratio0.44
Price to Book (P/B)3.11
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
4892 FAQ
What was Cyfuse Biomedical K.K.’s price range in the past 12 months?
Cyfuse Biomedical K.K. lowest stock price was ¥430.00 and its highest was ¥1412.00 in the past 12 months.
What is Cyfuse Biomedical K.K.’s market cap?
Cyfuse Biomedical K.K.’s market cap is ¥6.80B.
When is Cyfuse Biomedical K.K.’s upcoming earnings report date?
Cyfuse Biomedical K.K.’s upcoming earnings report date is Aug 19, 2025 which is in 47 days.
How were Cyfuse Biomedical K.K.’s earnings last quarter?
Cyfuse Biomedical K.K. released its earnings results on May 15, 2025. The company reported -¥19.9 earnings per share for the quarter, missing the consensus estimate of N/A by -¥19.9.
Is Cyfuse Biomedical K.K. overvalued?
According to Wall Street analysts Cyfuse Biomedical K.K.’s price is currently Overvalued.
Does Cyfuse Biomedical K.K. pay dividends?
Cyfuse Biomedical K.K. does not currently pay dividends.
What is Cyfuse Biomedical K.K.’s EPS estimate?
Cyfuse Biomedical K.K.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Cyfuse Biomedical K.K. have?
Cyfuse Biomedical K.K. has 8,373,600 shares outstanding.
What happened to Cyfuse Biomedical K.K.’s price movement after its last earnings report?
Cyfuse Biomedical K.K. reported an EPS of -¥19.9 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -2.002%.
Which hedge fund is a major shareholder of Cyfuse Biomedical K.K.?
Currently, no hedge funds are holding shares in JP:4892
Company Description
Cyfuse Biomedical K.K.
Cyfuse Biomedical K.K. is a pioneering company in the field of regenerative medicine and tissue engineering. The company specializes in developing innovative 3D bioprinting technologies aimed at creating functional human tissues and organs. Cyfuse's core products include its proprietary Regenova 3D bioprinter, which facilitates the fabrication of scaffold-free tissue constructs for medical research, drug development, and potential therapeutic applications.
Technical Analysis
Morishita Jintan Co., Ltd.
―
Symbio Pharmaceuticals Limited
―
Medrx Co., Ltd.
―
Modalis Therapeutics Corporation
―
Solasia Pharma KK
―